Maylene Alegre

University of California San Diego

Papers

1

Total Citations

3

H-Index

1

About

Dr. Maylene Alegre is a clinical researcher whose work centers on advancing cardiac electrophysiology, particularly through the evaluation of novel ablation technologies for arrhythmia treatment. Her most notable contribution is a landmark randomized controlled trial comparing the Amigo® robotic system to manual catheter ablation for cavo-tricuspid isthmus procedures, using a contact force ablation catheter. This study, published in 2018, provided critical evidence on the safety and efficacy of robotic-assisted ablation, a key step toward improving precision and reducing operator fatigue in interventional cardiology. Though her citation count is modest, her work holds significant translational value, directly informing clinical practice and device development. Dr. Alegre’s research exemplifies the rigorous, patient-centered approach needed to bridge engineering innovation and bedside care, making her a valuable voice in the ongoing evolution of minimally invasive cardiac procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Randomized controlled trial of Amigo® robotically controlled versus manually controlled ablation of the cavo-tricuspid isthmus using a contact force ablation catheter
3 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of California San Diego

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago